Showing results (251-260 of 276) with videos related to

Sort By:
Pageof 28
Drug Design, Development and Therapy|January 11, 2020
Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese ChildrenQian Li, Kai Wang, Hai-Yan Shi, et al.
British Journal of Clinical Pharmacology|August 27, 2021
Clinical utiliy of a model-based piperacillin dose in neonates with early-onset sepsisYue-E Wu, Shan-Shan Hou, Zeng-Yu Fang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2025
Synergistic regulation of metal-organic cage architectures via temperature- and solvent-driven atropisomerismJiaqi Liang, Li-Jun Peng, Ke-Lin Zhu, et al.
Molecular Cancer Therapeutics|May 10, 2019
SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK InhibitorsHengyu Lu, Chen Liu, Roberto Velazquez, et al.
Nature Methods|June 1, 2021
Three-dimensional adaptive optical nanoscopy for thick specimen imaging at sub-50-nm resolutionXiang Hao, Edward S Allgeyer, Dong-Ryoung Lee, et al.
Journal of Inflammation Research|June 3, 2021
Downregulation of Renal MRPs Transporters in Acute Lymphoblastic Leukemia Mediated by the IL-6/STAT3/PXR Signaling PathwayYue Zhou, Ai-Qing Nie, Shang Chen, et al.
Nature|May 12, 2012
ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive mannerHuai-Xiang Hao, Yang Xie, Yue Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2013
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinomaXiaomo Jiang, Huai-Xiang Hao, Joseph D Growney, et al.
Molecular Cancer Therapeutics|March 1, 2015
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor EverolimusHung Huynh, Huai-Xiang Hao, Stephen L Chan, et al.
Pageof 28